EDELVAISSNCT06656104
Impact of a Multi-infusion Strategy in Neonatology on the Rate of Central Line-associated Bloodstream Infections
At risk: Primary completion moved at least 9 months later.
Free. We email you which fields changed when ClinicalTrials.gov updates this record.
Record History
All 3 versions: 3 with changes below. See every version on ClinicalTrials.gov ↗
- Notable Primary and study completion pushed from Nov 1, 2026 to Aug 14, 2027
- Eligibility criteria expanded, about 11 words
- Enrollment increased: 455 → 569 participants
- Site details revised at 3 of 3 sites
- Notable Trial status: Not Yet Recruiting to Recruiting
- Start date changed from estimate of Jan 1, 2025 to Jan 14, 2025
- Site details revised at 3 of 3 sites
- Study First Submitted
- Notable: the plan changed
Endpoints
Primary
Arms and interventions
The center used the routine strategy based on the usual catheters and infusion systems (reference strategy). The duration of this period depending to the randomization of the center (i.e. 4 months, 8 months or 12 months)
At the end of the reference period, center will progressively switch to the new multi-infusion strategy (experimental strategy). The center used the Multiline Neo system to the routine strategy. The duration of this period depending to the randomization of the center (i.e. 12 months, 8 months or 4 months)
Devices: Reference strategy, Experimental strategy
Sites
3 sites in 1 country